Document is current
Any future updates will be listed below
-
Authors
Spencer, Andrew
Walker, Patricia
Asvadi, Parisa
Campbell, Douglas H.
Reed, Kate
Herbert, Ben R.
Breen, Edmond J.
Copeman, Michael C.
Dunn, Rosanne D.
- License Information
-
More Information
Article History
Received: 16 November 2018
Revised: 16 February 2019
Accepted: 24 April 2019
First Online: 31 July 2019
Conflict of interest
: P.A. is a former employee of Immune System Therapeutics. D.H.C. was an employee of Immune System Therapeutics and owns shares in HaemaLogiX Pty Ltd. B.R.H. and E.J.B. were consultants to HaemaLogiX. M.C.C. is a medical advisor and provided editorial assistance to HaemaLogiX. R.D.D. is an employee of HaemaLogiX and owns shares in HaemaLogiX. A.S. is an advisor to and received research funding from HaemaLogix. Julie A. Ely, Ph.D., CMPP provided medical writing assistance and was funded by HaemaLogiX. Rhonda Oshanek, BSc is a medical writer employed by HaemaLogiX. The other authors declare that they have no conflict of interest.
